Release The Power Of Precise Proteomics

Accelerating proteomics-driven precision medicine

Precision Biomarker Laboratories, a commercial contract research organization (CRO) wholly owned by Cedars-Sinai Medical Center, provides complete proteomics solutions across biomarker discovery, validation and CAP/CLIA-certified laboratory testing capabilities.  Our customized workflows allow for the quick translation from protein discovery to clinically validated targeted panels.

Let's Discuss Your Goals

Innovative and Integrated Solutions

1 - Contract Research

  • Discovery and early proteomics research support
  • Ready-to-go targeted assays
  • Clinically relevant protein biomarkers
  • Robust mass spectrometry technology and expertise

2 - Commercial Development

  • Advanced analytical methods for clinical and commercial deployment
  • Access to Cedars-Sinai clinical expertise and cohorts
  • Bioinformatics and data analysis platforms for clinical investigations

3 - Clinical Specialty

  • Complete translation to clinical application
  • Develop assays with defined clinical validity
  • Support validated assays from external sources

Accelerate your breakthrough
drugs and diagnostics

Drug Discovery

  • Accelerate discovery with integrated proteomics workflows
  • Precise results for informed decisions at every stage of development
  • Tailored solutions to fit your asset launch goals

    • Pre-Clinical Studies

  • Identify, characterize, and validate targets across all sample types
  • Leverage clinical expertise for biomarker validation
  • Flexible workflows for clinical trial success
  • Robust processes for diverse biological samples

    • Diagnostics

  • Discover novel biomarkers for diagnosing and predicting disease progression
  • Develop customized multi-biomarker panels for swift clinical decisions
  • Utilize GLP and CAP/CLIA-certified laboratory capabilities

    • Partner With Us

    Our Services

    Discovery Proteomics

    Revealing the whole proteome through deep protein profiling and quantification of thousands of proteins from various sample types (blood, plasma, cells, tissues, and other physiological fluids).

    Targeted Proteomics

    Target protein detection and validation with high sensitivity, specificity, reproducibility and quantitative accuracy. Powered by mass spectrometry and immunoassay technologies: Olink®, Quanterix™ and Meso Scale Discovery.

    Translational Proteomics

    Amplifying the value of proteomics with customized biomarker panels, for faster clinical decisions and drug development.

    Expanded Technologies and Solutions

    olink_logo
    MicrosoftTeams-image (43)
    seer_logo_big
    iso_logo
    msd_logo_big
    neoteryx_logo

    The proteome is a dynamic indicator of health

    Unlike the genome, the proteome changes over time and throughout the life builds up a tremendous complexity. From around 22000 human genes, more than a million proteoforms are translated, forming a dynamic pool of indicators for health and illness.

    Proteomics provides valuable data:

    Analyzing the proteome provides multiple layers of information about proteins like expression, function, structure, subcellular location, post-translational modifications (PTMs) and protein-protein interactions.

    Combining layers of proteome knowledge reveal insights into:

    • Impact of disease triggers
    • Mechanism of a disease
    • Treatment opportunities and intervention

    Let's connect

    Discuss and plan your next project with our talented team of proteomics experts!

    Contact Us